Shields to head Artomick

William Shields, named CEO of Artomick, a medication management and technology company.

Artomick International has named William Shields, R.Ph., as its new CEO. Artomick develops medication management and healthcare technology solutions for acute and long-term care markets. J.M. Romick, the founder and former CEO, is retiring from the company. Most recently Shields served as the senior VP strategic initiatives at AmerisourceBergen.

To see more Daily News articles, click here.

To go to the Drug Topics homepage, click here.